Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNONW) Cash from Financing Activities (2021 - 2025)

Historic Cash from Financing Activities for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to $59000.0.

  • Tenon Medical's Cash from Financing Activities fell 9938.8% to $59000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 5857.77%. This contributed to the annual value of $14.1 million for FY2024, which is 12413.52% up from last year.
  • According to the latest figures from Q3 2025, Tenon Medical's Cash from Financing Activities is $59000.0, which was down 9938.8% from -$59000.0 recorded in Q2 2025.
  • Over the past 5 years, Tenon Medical's Cash from Financing Activities peaked at $14.2 million during Q2 2022, and registered a low of -$179000.0 during Q4 2021.
  • Over the past 5 years, Tenon Medical's median Cash from Financing Activities value was $266000.0 (recorded in 2023), while the average stood at $3.1 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 1050714.29% in 2024, then tumbled by 9938.8% in 2025.
  • Tenon Medical's Cash from Financing Activities (Quarter) stood at -$179000.0 in 2021, then surged by 86.03% to -$25000.0 in 2022, then soared by 5584.0% to $1.4 million in 2023, then plummeted by 91.76% to $113000.0 in 2024, then crashed by 47.79% to $59000.0 in 2025.
  • Its Cash from Financing Activities stands at $59000.0 for Q3 2025, versus -$59000.0 for Q2 2025 and $6.3 million for Q1 2025.